Cyclacel pharmaceuticals reports fourth quarter financial results and provides business update

Berkeley heights, n.j., april 02, 2025 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; “cyclacel” or the “company”), a biopharmaceutical company developing innovative medicines, today announced fourth quarter financial results and provided a business update.
CYCC Ratings Summary
CYCC Quant Ranking